Catalio Capital Management, LP
40 holdingsFiling period: 2026-06-30Current AUM: $494.2Mestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | AVLN | Avalyn Pharmaceuticals Inc | 1.68M | $55.2M | $45.7M | 9.24% | -- | 2026-06-30 |
| 2 | JNJ | Johnson & Johnson | 138.9K | $35.3M | $37.2M | 7.52% | -- | 2026-06-30 |
| 3 | GILD | Gilead Sciences Inc | 269.3K | $34.0M | $42.3M | 8.57% | +105.4K | 2026-06-30 |
| 4 | BBIO | Bridgebio Pharma Inc | 455.0K | $33.9M | $31.0M | 6.27% | +23.0K | 2026-06-30 |
| 5 | SNDX | Syndax Pharmaceuticals Inc | 1.22M | $26.6M | $16.5M | 3.34% | +172.0K | 2026-06-30 |
| 6 | DFTX | Definium Therapeutics Inc | 562.7K | $26.5M | $20.3M | 4.10% | -475,312 | 2026-06-30 |
| 7 | BMY | Bristol-Myers Squibb Co | 413.0K | $23.8M | $26.0M | 5.26% | -7,766 | 2026-06-30 |
| 8 | PBLS | Parabilis Medicines Inc | 824.0K | $22.6M | $22.2M | 4.49% | -- | 2026-06-30 |
| 9 | NTRA | Natera Inc | 82.2K | $22.3M | $33.0M | 6.67% | +11.3K | 2026-06-30 |
| 10 | INCY | Incyte Corp | 191.6K | $21.7M | $22.4M | 4.53% | +9.5K | 2026-06-30 |
| 11 | SEPN | Septerna Inc | 536.2K | $18.0M | $21.9M | 4.44% | +241.8K | 2026-06-30 |
| 12 | MLYS | Mineralys Therapeutics Inc | 648.7K | $17.5M | $13.9M | 2.82% | +209.7K | 2026-06-30 |
| 13 | HTFL | Heartflow Inc | 583.1K | $17.1M | $32.3M | 6.54% | +179.5K | 2026-06-30 |
| 14 | CRVS | Corvus Pharmaceuticals Inc | 1.08M | $16.1M | $11.5M | 2.33% | +189.0K | 2026-06-30 |
| 15 | GPCR | Structure Therapeutics Inc | 276.6K | $14.8M | $6.1M | 1.23% | +21.2K | 2026-06-30 |
| 16 | PTGX | Protagonist Therapeutics Inc | 106.8K | $13.1M | $14.9M | 3.02% | -- | 2026-06-30 |
| 17 | IRON | Disc Medicine Inc | 159.4K | $11.7M | $12.0M | 2.42% | +36.4K | 2026-06-30 |
| 18 | EW | Edwards Lifesciences Corp | 124.8K | $11.3M | $11.2M | 2.27% | -19,829 | 2026-06-30 |
| 19 | AXSM | Axsome Therapeutics Inc. | 43.2K | $10.6M | $6.7M | 1.36% | -- | 2026-06-30 |
| 20 | RARE | Ultragenyx Pharmaceutical in | 316.3K | $10.6M | $5.0M | 1.02% | -534,545 | 2026-06-30 |
| 21 | KLRA | Kailera Therapeutics Inc | 468.8K | $10.3M | $6.2M | 1.26% | -- | 2026-06-30 |
| 22 | KPTI | Karyopharm Therapeutics Inc | 940.9K | $9.2M | $514K | 0.10% | +43.1K | 2026-06-30 |
| 23 | ODTX | Odyssey Therapeutics Inc | 457.8K | $8.6M | $8.7M | 1.77% | -- | 2026-06-30 |
| 24 | — | Ascendis Pharma A/S | 31.8K | $8.5M | $8.5M | 1.71% | -- | 2026-06-30 |
| 25 | KARD | Kardigan Inc | 312.5K | $7.5M | $4.0M | 0.81% | -- | 2026-06-30 |
← Scroll →
Page 1 of 2